Regeneron Pharmaceuticals Contracts & Agreements

208 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
VestType
Regeneron Pharmaceuticals
Biotechnology
NY
2016
Amendment No. 3 to Master Agreement, dated as of August 1, 2024, by and between Regeneron Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc
Regeneron Pharmaceuticals
2024
Amendment No
Regeneron Pharmaceuticals
2024
Form of stock option agreement and related notice of grant for use in connection with the grant of non-qualified stock options to the Registrant's executive officers under the...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2024
Form of restricted stock award agreement and related notice of grant for use in connection with the grant of restricted stock awards to the Registrant's executive officers under...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2024
First Amendment to Amended and Restated License and Collaboration Agreement by and between the Registrant and Aventis Pharmaceuticals Inc., dated May 1, 2013
Collaboration Agreements
Regeneron Pharmaceuticals
2023
Amendment No. 1 to Master Agreement, dated as of April 10, 2023, by and between the Registrant and Alnylam Pharmaceuticals, Inc
Regeneron Pharmaceuticals
2023
Waiver and Consent, dated as of April 14, 2023, pursuant to the Amended and Restated Employment Agreement, dated as of November 14, 2008, between the Registrant and Leonard S....
Employment Agreements
Regeneron Pharmaceuticals
2023
First Amendment to the Regeneron Pharmaceuticals, Inc. Cash Incentive Bonus Plan
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2023
Third Amended and Restated Participation Agreement, dated as of March 27, 2023, by and among Old Saw Mill Holdings LLC, as lessee, Bank of America, N.A., as administrative agent,...
Participation Agreements
Regeneron Pharmaceuticals
2023
Third Amended and Restated Lease and Remedies Agreement, dated as of March 27, 2023, between Old Saw Mill Holdings LLC, as lessee, and BA Leasing BSC, LLC, as lessor
Lease Agreements
Regeneron Pharmaceuticals
2023
Third Amended and Restated Guaranty, dated as of March 27, 2023, made by Regeneron Pharmaceuticals, Inc., Regeneron Healthcare Solutions, Inc., and Regeneron Genetics Center LLC,...
Guaranty Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2023
Credit Agreement, dated as of December 19, 2022, by and among Regeneron Pharmaceuticals, Inc., as a borrower and guarantor; certain direct subsidiaries of Regeneron...
Credit Agreements
Regeneron Pharmaceuticals
2022
Modification No. 02 to Base Agreement, dated as of August 2, 2022, by and between Regeneron Pharmaceuticals, Inc. (the "Registrant") and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
2022
Modification No. 03 to Project Agreement, dated as of May 21, 2021, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
2022
Modification No. 04 to Project Agreement, dated as of July 12, 2021, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
2022
Modification No. 06 to Project Agreement, dated as of July 12, 2022, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification P00001 to Supply Agreement, dated as of March 9, 2021, by and between the Registrant and the U.S. Army Contracting Command, New Jersey
Supply Agreements
Regeneron Pharmaceuticals
2022
Modification P00002 to Supply Agreement, dated as of June 17, 2021, by and between the Registrant and the U.S. Army Contracting Command, New Jersey
Supply Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification P00003 to Supply Agreement, dated as of July 8, 2021, by and between the Registrant and the U.S. Army Contracting Command, New Jersey
Supply Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification P00007 to Supply Agreement, dated as of July 29, 2022, by and between the Registrant and the U.S. Army Contracting Command, New Jersey
Supply Agreements
Regeneron Pharmaceuticals
2022
Modification No. 0
Modification Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Amended and Restated Immuno-Oncology License and Collaboration Agreement, dated as of June 1, 2022, by and between the Registrant and Sanofi Biotechnology SAS
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
Fifth Amendment to Amended and Restated License and Collaboration Agreement, dated as of June 1, 2022, by and between the Registrant, Sanofi Biotechnology SAS, and Sanofi
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification No. 1 to Base Agreement, dated as of January 26, 2022, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
2022
Modification No. 5 to Project Agreement, dated as of March 22, 2022, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
2022
Modification P00006 to Supply Agreement, dated as of February 24, 2022, by and between the Registrant and the U.S. Army Contracting Command, New Jersey
Supply Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Second Amended and Restated Participation Agreement, dated as of March 2, 2022, by and among Old Saw Mill Holdings LLC, as lessee, Bank of America, N.A., as administrative agent,...
Participation Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
Second Amended and Restated Lease and Remedies Agreement, dated as of March 2, 2022, between Old Saw Mill Holdings LLC, as lessee, and BA Leasing BSC, LLC, as lessor
Lease Agreements
Regeneron Pharmaceuticals
2022
Second Amended and Restated Guaranty, dated as of March 2, 2022, made by Regeneron Pharmaceuticals, Inc., Regeneron Healthcare Solutions, Inc., and Regeneron Genetics Center LLC,...
Guaranty Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2022
Fourth Amendment to Amended and Restated License and Collaboration Agreement, dated as of October 6, 2021, by and between the Registrant, Sanofi Biotechnology SAS, and Sanofi
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Amendment No. 1 to Credit Agreement, dated as of November 11, 2021, by and among the Registrant, as a borrower and guarantor; certain direct subsidiaries of the Registrant, as...
Credit Agreements
Regeneron Pharmaceuticals
2022
First Amendment to Immuno-oncology License and Collaboration Agreement, dated as of October 6, 2021, by and between the Registrant and Sanofi Biotechnology SAS
Collaboration Agreements
Regeneron Pharmaceuticals
2022
First Amendment to Amended and Restated Participation Agreement, dated as of October 6, 2021, by and among Old Saw Mill Holdings LLC, as lessee; the Registrant, as parent...
Participation Agreements
Regeneron Pharmaceuticals
Biotechnology
2022
Modification P00004 to Supply Agreement, dated as of July 26, 2021, by and between Regeneron Pharmaceuticals, Inc. (the "Registrant") and the U.S. Army Contracting Command, New...
Supply Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Modification P00005 to Supply Agreement, dated as of September 14, 2021, by and between the Registrant and the U.S. Army Contracting Command, New Jersey
Supply Agreements
Regeneron Pharmaceuticals
2021
Form of stock option agreement and related notice of grant for use in connection with the grant of non-qualified stock options to the Registrant's executive officers under the...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2021
Form of stock option agreement and related notice of grant for use in connection with the grant of non-qualified stock options to P. Roy Vagelos, M.D. under the Second Amended and...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2021
Form of restricted stock award agreement and related notice of grant for use in connection with the grant of restricted stock awards to the Registrant's executive officers under...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Form of restricted stock unit award agreement and related notice of grant for use in connection with the grant of restricted stock units to P. Roy Vagelos, M.D. under the Second...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2021
Form of stock option agreement and related notice of grant for use in connection with the grant of non-qualified stock options to the Registrant's non-employee directors under the...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2021
Form of restricted stock unit award agreement and related notice of grant for use in connection with the grant of restricted stock units to the Registrant's non-employee directors...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Form of performance restricted stock unit award agreement and related notice of grant for use in connection with the grant of performance restricted stock units to Leonard S....
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2021
Project Agreement, dated as of July 6, 2020, by and between the Registrant and Advanced Technology International
Regeneron Pharmaceuticals
Biotechnology
2021
Modification No. 01 to Project Agreement, dated as of October 13, 2020, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
2021
Modification No. 02 to Project Agreement, dated as of November 17, 2020, by and between the Registrant and Advanced Technology International
Modification Agreements
Regeneron Pharmaceuticals
2021
Base Agreement, dated as of July 6, 2020, by and between the Registrant and Advanced Technology International
Regeneron Pharmaceuticals
Biotechnology
2020
Project Agreement, dated as of July 6, 2020, by and between the Registrant and Advanced Technology International
Regeneron Pharmaceuticals
Biotechnology
2020
License Agreement, dated as of August 18, 2020, by and among the Registrant, F. Hoffman-La Roche Ltd, and Genentech, Inc
License Agreements
Regeneron Pharmaceuticals
2020
Underwriting Agreement, dated August 7, 2020, by and among the Company, Goldman Sachs & Co. LLC, BofA Securities, Inc., and J.P. Morgan Securities LLC, as representatives of the...
Underwriting Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Indenture, dated August 12, 2020, between the Company and U.S. Bank National Association
Indenture Agreements
Regeneron Pharmaceuticals
2020
First Supplemental Indenture, dated August 12, 2020, between the Company and U.S. Bank National Association
Indenture Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Amendment No. 1 to Credit Agreement, dated as of June 11, 2020, by and between the Registrant, as borrower, and Goldman Sachs Bank USA, as administrative agent
Credit Agreements
Regeneron Pharmaceuticals
2020
Third Amendment to Amended and Restated License and Collaboration Agreement, dated as of April 5, 2020, and effective as of April 1, 2020, by and between the Registrant, Sanofi...
Collaboration Agreements
Regeneron Pharmaceuticals
2020
Praluent Cross License & Commercialization Agreement, dated as of April 5, 2020, and effective as of April 1, 2020, by and between the Registrant and Sanofi Biotechnology SAS
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Underwriting Agreement, dated as of May 26, 2020, by and among Regeneron Pharmaceuticals, Inc., Sanofi, Aventisub LLC, and BofA Securities, Inc. and Goldman Sachs & Co. LLC, as...
Underwriting Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Stock Repurchase Agreement, dated as of May 25, 2020, by and between Regeneron Pharmaceuticals, Inc. and Sanofi
Repurchase Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Amendment to the Amended and Restated Investor Agreement, dated as of May 25, 2020, by and among Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis US LLC, and Aventisub LLC
Regeneron Pharmaceuticals
2020
Credit Agreement, dated as of May 25, 2020, by and among Regeneron Pharmaceuticals, Inc., as borrower; Goldman Sachs Bank USA, as administrative agent, sole bookrunner, sole lead...
Credit Agreements
Regeneron Pharmaceuticals
2020
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Regeneron Pharmaceuticals
2020
Form of stock option agreement and related notice of grant for use in connection with the grant of non-qualified stock options to the Registrant's executive officers under the...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2020
Form of stock option agreement and related notice of grant for use in connection with the grant of non-qualified stock options to P. Roy Vagelos, M.D. under the Amended and...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2020
Form of restricted stock award agreement and related notice of grant for use in connection with the grant of restricted stock awards to the Registrant's executive officers under...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2020
Form of stock option agreement and related notice of grant for use in connection with the grant of non-qualified stock options to the Registrant's non-employee directors under the...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2020
Form of restricted stock unit award agreement and related notice of grant for use in connection with the grant of restricted stock units to the Registrant's non-employee directors...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2020
Form of performance restricted stock unit award agreement and related notice of grant for use in connection with the grant of performance restricted stock units to Leonard S....
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2020
Second Amendment Agreement, dated December 19, 2019, by and between Bayer HealthCare LLC and the Registrant
Regeneron Pharmaceuticals
Biotechnology
2020
Investor Agreement, dated as of April 8, 2019, by and between the Registrant and Alnylam Pharmaceuticals, Inc
Regeneron Pharmaceuticals
Biotechnology
MA
2019
Stock Purchase Agreement, dated as of April 8, 2019, by and between the Registrant and Alnylam Pharmaceuticals, Inc
Stock Agreements
Regeneron Pharmaceuticals
2019
Master Agreement, dated as of April 8, 2019, by and between the Registrant and Alnylam Pharmaceuticals, Inc
Regeneron Pharmaceuticals
2019
Form of Co-Co Collaboration Agreement (Exhibit B to Master Agreement contained in Exhibit 10.4)
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Form of License Agreement (Exhibit C to Master Agreement contained in Exhibit 10.4)
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Amended and Restated Guaranty, dated as of May 2, 2019, made by Regeneron Pharmaceuticals, Inc., Regeneron Healthcare Solutions, Inc., and Regeneron Genetics Center LLC, as...
Guaranty Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Amended and Restated Participation Agreement, dated as of May 2, 2019, by and among Old Saw Mill Holdings LLC, as lessee; Bank of America, N.A., as administrative agent; BA...
Participation Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Amended and Restated Lease and Remedies Agreement, dated as of May 2, 2019, between Old Saw Mill Holdings LLC, as lessee, and BA Leasing BSC, LLC, as lessor
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Form of stock option agreement and related notice of grant for use in connection with the grant of non-qualified stock options to the Registrant's executive officers under the...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Form of stock option agreement and related notice of grant for use in connection with the grant of non-qualified stock options to P. Roy Vagelos, M.D. under the Amended and...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2019
Form of restricted stock award agreement and related notice of grant for use in connection with the grant of restricted stock awards to the Registrant's executive officers under...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2019
Form of stock option agreement and related notice of grant for use in connection with the grant of non-qualified stock options to the Registrant's non-employee directors under the...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2019
Form of restricted stock unit award agreement and related notice of grant for use in connection with the grant of restricted stock units to the Registrant's non-employee directors...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2019
Amended and Restated Immuno-oncology Discovery and Development Agreement, executed on January 2, 2019 and effective as of December 31, 2018, by and between the Registrant and...
Development Agreements
Regeneron Pharmaceuticals
2019
Retirement Agreement, effective as of January 5, 2018, by and between Regeneron Pharmaceuticals, Inc. and Robert J. Terifay
Retirement Agreements
Regeneron Pharmaceuticals
2018
Letter Agreement, dated as of January 7, 2018, by and among Regeneron Pharmaceuticals, Inc., Sanofi, sanofi-aventis US LLC, Aventis Pharmaceuticals Inc., sanofi-aventis Amrique du...
Regeneron Pharmaceuticals
Biotechnology
2018
Form of stock option agreement and related notice of grant for use in connection with the grant of non-qualified stock options to the Registrant's executive officers under the...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2018
Form of stock option agreement and related notice of grant for use in connection with the grant of incentive stock options to the Registrant's executive officers under the Amended...
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2018
Form of stock option agreement and related notice of grant for use in connection with the grant of non-qualified stock options to P. Roy Vagelos, M.D. under the Amended and...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2018
Form of stock option agreement and related notice of grant for use in connection with the grant of incentive stock options to P. Roy Vagelos, M.D. under the Amended and Restated...
Stock Agreements
Regeneron Pharmaceuticals
2018
Form of restricted stock award agreement and related notice of grant for use in connection with the grant of restricted stock awards to the Registrant's executive officers under...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
2018
Form of stock option agreement and related notice of grant for use in connection with the grant of non-qualified stock options to the Registrant's non-employee directors under the...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2018
CONSENT AND AMENDMENT NO. 1 MEMORANDUM
Regeneron Pharmaceuticals
Biotechnology
2017
Date:February 22, 2016To:Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, NY 10591-6707Attention:Dominick AgronVP and Treasurer777 Old Saw Mill River...
Warrant Agreements
Regeneron Pharmaceuticals
2016
VestType
Regeneron Pharmaceuticals
2016
Regeneron Pharmaceuticals, Inc.Notice of Grant of Stock OptionsID:[]and Option Agreement777 Old Saw Mill River RoadTarrytown, New York 10591[OPTIONEE NAME]OptionNumber:[][OPTIONEE...
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2016
Date:November 15, 2015To:Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, NY 10591-6707Attention:Dominick AgronVP and Treasurer777 Old Saw Mill River...
Credit Agreements
Regeneron Pharmaceuticals
2016
Vest Type
Regeneron Pharmaceuticals
2015
Vest Type
Regeneron Pharmaceuticals
2015
ID: [ ] Notice of Grant of Award 777 Old Saw Mill River Road And Award Agreement Tarrytown, New York 10591 [NAME] Award Number: [ ] [ADDRESS] Plan: [ ]
Regeneron Pharmaceuticals
2015
IMMUNO-ONCOLOGY DISCOVERY AND DEVELOPMENT AGREEMENT By and Between SANOFI BIOTECHNOLOGY SAS and REGENERON PHARMACEUTICALS, INC. Dated as of July 1, 2015 CERTAIN PORTIONS OF THIS...
Confidentiality Agreements
Regeneron Pharmaceuticals
2015
IMMUNO-ONCOLOGY LICENSE AND COLLABORATION AGREEMENT By and Between SANOFI BIOTECHNOLOGY SAS and REGENERON PHARMACEUTICALS, INC. Dated as of July 1, 2015 CERTAIN PORTIONS OF THIS...
Confidentiality Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
AMENDMENT NO. 1 TO AMENDED AND RESTATED DISCOVERY AND PRECLINICAL DEVELOPMENT AGREEMENT
Development Agreements
Regeneron Pharmaceuticals
2015
AMENDMENT NO. 2 TO AMENDED AND RESTATED LICENSE AND COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2015
Date:August 5, 2015To:Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, NY 10591-6707Attention:Dominick AgronVP and Treasurer777 Old Saw Mill River...
Warrant Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
SEVENTEENTH AMENDMENT TO LEASE
Lease Agreements
Regeneron Pharmaceuticals
2015
COLLABORATION AGREEMENT by and between REGENERON IRELAND and MITSUBISHI TANABE PHARMA CORPORATION CERTAIN PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR...
Confidentiality Agreements
Regeneron Pharmaceuticals
2015
TENTH AMENDMENT TO LEASE
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2015
FOURTEENTH AMENDMENT TO LEASE
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2015
FIFTEENTH AMENDMENT TO LEASE
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2015
SIXTEENTH AMENDMENT TO LEASE
Lease Agreements
Regeneron Pharmaceuticals
2015
FIRST AMENDMENT TO MT. PLEASANT LEASE
Lease Agreements
Regeneron Pharmaceuticals
2015
Regeneron Pharmaceuticals, Inc. Cash Incentive Bonus Plan
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2015
AMENDED AND RESTATED COLLABORATION AGREEMENT By and Between SANOFI-AVENTIS US, LLC and REGENERON PHARMACEUTICALS, INC. Dated as of February 23, 2015 TABLE OF CONTENTS
Collaboration Agreements
Regeneron Pharmaceuticals
2015
RESTATED AMENDMENT AGREEMENT
Regeneron Pharmaceuticals
Biotechnology
2015
Annex A Unwind Period PriceAmendment Payment Amount per Warrant$370.00$273.46$375.00$278.44$380.00$283.43$385.00$288.41$390.00$293.40$395.00$298.38$397.75$301.07
Regeneron Pharmaceuticals
2015
Amendment, dated as of May 13, 2014, to the Master Terms and Conditions for Warrants, dated as of October 18, 2011, as supplemented by a confirmation dated October 18, 2011,...
Regeneron Pharmaceuticals
Biotechnology
NY
2014
Amendment, dated as of May 14, 2014, to the Master Terms and Conditions for Warrants, dated as of October 18, 2011, as supplemented by a confirmation dated October 18, 2011,...
Credit Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2014
Amendment, dated as of May 15, 2014, to the Master Terms and Conditions for Warrants, dated as of October 18, 2011, as supplemented by a confirmation dated October 18, 2011,...
Regeneron Pharmaceuticals
2014
Amendment, dated as of May 16, 2014, to the Master Terms and Conditions for Warrants, dated as of October 18, 2011, as supplemented by a confirmation dated October 18, 2011,...
Regeneron Pharmaceuticals
Biotechnology
NY
2014
REGENERON PHARMACEUTICALS, INC. Non-Qualified Stock Option OPTION AGREEMENT PURSUANT TO THE REGENERON PHARMACEUTICALS, INC. 2014 LONG-TERM INCENTIVE PLAN
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2014
REGENERON PHARMACEUTICALS, INC. Incentive Stock Option OPTION AGREEMENT PURSUANT TO THE REGENERON PHARMACEUTICALS, INC. 2014 LONG-TERM INCENTIVE PLAN
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2014
REGENERON PHARMACEUTICALS, INC. RESTRICTED STOCK AGREEMENT PURSUANT TO THE REGENERON PHARMACEUTICALS, INC. 2014 LONG-TERM INCENTIVE PLAN
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2014
REGENERON PHARMACEUTICALS, INC. Non-Qualified Stock Option OPTION AGREEMENT PURSUANT TO THE REGENERON PHARMACEUTICALS, INC. 2014 LONG-TERM INCENTIVE PLAN (Non-Employee Director...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2014
AMENDMENT NO. 1 TO THE REGENERON PHARMACEUTICALS, INC. SECOND AMENDED AND RESTATED 2000 LONG-TERM INCENTIVE PLAN
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2014
AMENDED AND RESTATED INVESTOR AGREEMENT By and Among SANOFI, SANOFI-AVENTIS US LLC, AVENTIS PHARMACEUTICALS INC., SANOFI-AVENTIS AMÉRIQUE DU NORD AND REGENERONPHARMACEUTICALS,...
Regeneron Pharmaceuticals
2014
MT. PLEASANT LEASE by and between BMR-Landmark at Eastview LLC, a Delaware limited liability company and Regeneron Pharmaceuticals, Inc., a New York corporation
Lease Agreements
Regeneron Pharmaceuticals
2013
ELEVENTH AMENDMENT TO LEASE
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2013
TWELFTH AMENDMENT TO LEASE
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2013
THIRTEENTH AMENDMENT TO LEASE
Lease Agreements
Regeneron Pharmaceuticals
2013
FIRST AMENDMENT TO AMENDED AND RESTATED LICENSE AND COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2013
[SANOFI LETTERHEAD]
Regeneron Pharmaceuticals
2013
AMENDED AND RESTATED NON-EXCLUSIVE LICENSE AND SETTLEMENT AGREEMENT
Settlement Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2013
NON-EXCLUSIVE LICENSE AND SETTLEMENT AGREEMENT
Settlement Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2013
Annexe 1
Regeneron Pharmaceuticals
Biotechnology
2013
AMENDMENT AGREEMENT
Regeneron Pharmaceuticals
2012
[Shares Vest Type Full Vest Expiration Date [10 years from Grant** On Vest Date [__/__/__]** Date] [10 years from Grant** On Vest Date [__/__/__]** Date] [10 years from Grant** On...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2012
NON-EXCLUSIVE LICENSE AND PARTIALSETTLEMENT AGREEMENT
License Agreements
Regeneron Pharmaceuticals
2012
EIGHTH AMENDMENT TO LEASE
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2011
NINTH AMENDMENT TO LEASE
Lease Agreements
Regeneron Pharmaceuticals
2011
REGENERON PHARMACEUTICALS, INC. 1.875% CONVERTIBLE SENIOR NOTES DUE 2016 PURCHASE AGREEMENT
Note Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
REGENERON PHARMACEUTICALS, INC. 1.875% CONVERTIBLE SENIOR NOTES DUE 2016 INDENTURE Dated as of October 21, 2011 WELLS FARGO BANK, NATIONAL ASSOCIATION Trustee
Indenture Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
REGENERON PHARMACEUTICALS, INC. 1.875% Convertible Senior Notes due 2016
Note Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2011
MASTER TERMS AND CONDITIONS FOR CONVERTIBLE BONDHEDGING TRANSACTIONS BETWEEN GOLDMAN, SACHS & CO. AND REGENERON PHARMACEUTICALS, INC.
Regeneron Pharmaceuticals
2011
MASTER TERMS AND CONDITIONS FOR BASE WARRANTS ISSUED BY REGENERON PHARMACEUTICALS, INC.
Regeneron Pharmaceuticals
2011
MASTER TERMS AND CONDITIONS FOR CONVERTIBLE BONDHEDGING TRANSACTIONS BETWEEN CITIBANK, N.A. AND REGENERON PHARMACEUTICALS, INC.
Regeneron Pharmaceuticals
Biotechnology
NY
2011
MASTER TERMS AND CONDITIONS FOR BASE WARRANTS ISSUED BY REGENERON PHARMACEUTICALS, INC.
Regeneron Pharmaceuticals
Biotechnology
NY
2011
MASTER TERMS AND CONDITIONS FOR CONVERTIBLE BONDHEDGING TRANSACTIONS BETWEEN CREDIT SUISSE INTERNATIONAL AND REGENERON PHARMACEUTICALS, INC.
Credit Agreements
Regeneron Pharmaceuticals
2011
MASTER TERMS AND CONDITIONS FOR BASE WARRANTS ISSUED BY REGENERON PHARMACEUTICALS, INC.
Regeneron Pharmaceuticals
Biotechnology
NY
2011
MASTER TERMS AND CONDITIONS FOR CONVERTIBLE BONDHEDGING TRANSACTIONS BETWEEN MORGAN STANLEY & CO. INTERNATIONAL PLC AND REGENERON PHARMACEUTICALS, INC.
Regeneron Pharmaceuticals
2011
MASTER TERMS AND CONDITIONS FOR BASE ADDITIONALWARRANTS ISSUED BY REGENERON PHARMACEUTICALS, INC.
Regeneron Pharmaceuticals
Biotechnology
NY
2011
1 REGENERON PHARMACEUTICALS, INC. RESTRICTED STOCK AGREEMENT PURSUANT TO THE 2000 LONG-TERM INCENTIVE PLAN
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2011
REGENERON PHARMACEUTICALS, INC. OPTION AGREEMENT PURSUANT TO THE 2000 LONG-TERM INCENTIVE PLAN
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2011
SEVENTH AMENDMENT TO LEASE
Lease Agreements
Regeneron Pharmaceuticals
2011
Amendment to the Non-Exclusive License and Material Transfer Agreement dated as of March 30, 2007
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2010
5,500,000 SHARES REGENERON PHARMACEUTICALS, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreements
Regeneron Pharmaceuticals
2010
SIXTH AMENDMENT TOLEASE
Regeneron Pharmaceuticals
Biotechnology
2010
AMENDED AND RESTATEDDISCOVERY AND PRECLINICAL DEVELOPMENT AGREEMENT By and Between AVENTIS PHARMACEUTICALSINC. and REGENERON PHARMACEUTICALS,INC. Dated as of November 10, 2009...
Development Agreements
Regeneron Pharmaceuticals
2010
AMENDED AND RESTATED LICENSE AND COLLABORATIONAGREEMENT By and Among AVENTIS PHARMACEUTICALS INC., SANOFI-AVENTIS AMERIQUE DUNORD and REGENERON PHARMACEUTICALS,INC. Dated as of...
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2010
First Amendment to the InvestorAgreement dated as of December 20, 2007
Regeneron Pharmaceuticals
Biotechnology
2010
IL-1 ANTIBODY TERMINATION AGREEMENT By and Between NOVARTIS PHARMA AG NOVARTIS PHARMACEUTICALS CORPORATION AND REGENERON PHARMACEUTICALS, INC. Dated as of June 8, 2009
Termination Agreements
Regeneron Pharmaceuticals
2009
TRAP -2 TERMINATION AGREEMENT By and Between NOVARTIS PHARMA AG NOVARTIS PHARMACEUTICALS CORPORATION AND REGENERON PHARMACEUTICALS, INC. Dated as of June 8, 2009
Termination Agreements
Regeneron Pharmaceuticals
2009
[Shares Vest Type Full Vest Expiration Date ** On Vest Date [__/__/__]** [10 years from Grant Date] ** On Vest Date [__/__/__]** [10 years from Grant Date] ** On Vest Date...
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2009
REGENERON PHARMACEUTICALS,INC. OPTION AGREEMENT PURSUANT TO THE 2000 LONG-TERMINCENTIVE PLAN
Regeneron Pharmaceuticals
2009
THIRD AMENDMENT TOLEASE
Regeneron Pharmaceuticals
Biotechnology
NY
2009
REGENERON PHARMACEUTICALS,INC. CHANGE IN CONTROL SEVERANCEPLAN As amended and restated, effectiveNovember 14, 2008 INTRODUCTION
Change of Control Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2009
EX-10.3: SECOND AMENDMENT TO LEASE
Lease Agreements
Regeneron Pharmaceuticals
2008
EX-4.1: FORM OF CERTIFICATE OF SHARES OF COMMON STOCK
Stock Agreements
Regeneron Pharmaceuticals
2008
EX-10.2: AMENDED AND RESTATED NON-EXCLUSIVE LICENSE AGREEMENT
License Agreements
Regeneron Pharmaceuticals
2008
EX-10.3: SUBSCRIPTION AGREEMENT
Subscription Agreements
Regeneron Pharmaceuticals
2008
REGENERON PHARMACEUTICALS, INC.
Regeneron Pharmaceuticals
2008
DISCOVERY AND PRECLINICAL DEVELOPMENT AGREEMENT
Development Agreements
Regeneron Pharmaceuticals
2008
LICENSE AND COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
2008
STOCK PURCHASE AGREEMENT
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2008
INVESTOR AGREEMENT
Regeneron Pharmaceuticals
Biotechnology
DE
2008
EX-10.1: FIRST AMENDMENT TO LEASE
Lease Agreements
Regeneron Pharmaceuticals
Biotechnology
2007
EX-10.1: NON-EXCLUSIVE LICENSE AND MATERIAL TRANSFER AGREEMENT
License Agreements
Regeneron Pharmaceuticals
2007
EX-10.14: NON EXCLUSIVE LICENSE AND MATERIAL TRANSFER AGREEMENT
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2007
7,600,000 SHARES REGENERON PHARMACEUTICALS, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2006
EX-10.1: LICENSE AND COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2006
EX-10.13.3: AMENDMENT NO. 3 TO COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
2006
EX-10.13.4: AMENDMENT NO. 4 TO COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
2006
EX-10.1: CHANGE IN CONTROL SEVERANCE PLAN
Change of Control Agreements
Regeneron Pharmaceuticals
2006
EX-10.01: FORM OF OPTION AGREEMENT
Regeneron Pharmaceuticals
2005
EX-10.02: FORM OF OPTION AGREEMENT
Regeneron Pharmaceuticals
2005
EX-10.10.1: AMENDMENT AND AGREEMENT
Regeneron Pharmaceuticals
2005
AMENDMENT #2 TO MANUFACTURING AGREEMENT
Regeneron Pharmaceuticals
2005
AMENDMENT #3 TO MANUFACTURING AGREEMENT
Regeneron Pharmaceuticals
Biotechnology
2005
AMENDMENT #4 TO MANUFACTURING AGREEMENT
Regeneron Pharmaceuticals
2005
AMENDMENT #5 TO MANUFACTURING AGREEMENT
Regeneron Pharmaceuticals
2005
EMPLOYMENT AGREEMENT
Employment Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2005
AMENDMENT NO. 1 TO COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
Biotechnology
2005
SECOND AMENDMENT TO COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
2005
FORM OF RESTRICTED STOCK AWARD AGREEMENT
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
2004
AMENDMENT NO.3 TO INCENTIVE PLAN
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2004
COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
2003
STOCK PURCHASE AGREEMENT
Stock Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2003
NON-EXCLUSIVE PATENT LICENSE AGREEMENT
License Agreements
Regeneron Pharmaceuticals
Biotechnology
NJ
2003
COLLABORATION, LICENSE AND OPTION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
2003
STOCK PURCHASE AGREEMENT
Stock Agreements
Regeneron Pharmaceuticals
2003
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
Regeneron Pharmaceuticals
2003
EX-10.6.1 AMENDMENT #1 TO LONG TERM INCENTIVE PLAN
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2003
EX-10.6.2 AMENDMENT #2 TO LONG TERM INCENTIVE PLAN
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
2003
EX-10.18 EMPLOYMENT AGREEMENT
Employment Agreements
Regeneron Pharmaceuticals
2003
EX-10.22: FOCUSED COLLABORATION AGREEMENT
Collaboration Agreements
Regeneron Pharmaceuticals
2002
LICENSE AGREEMENT
License Agreements
Regeneron Pharmaceuticals
2002
CERTIFICATE OF AMENDMENT OF CERTIFICATE OF INCORP
Regeneron Pharmaceuticals
Biotechnology
2002
2000 LONG-TERM INCENTIVE PLAN
Bonus & Incentive Agreements
Regeneron Pharmaceuticals
Biotechnology
NY
2002
AMENDMENT #1 TO MANUFACTURING AGREEMENT
Regeneron Pharmaceuticals
Biotechnology
2005
FORM OF OPTION AGREEMENT
Regeneron Pharmaceuticals
Biotechnology
NY
2004
FORM OF OPTION AGREEMENT
Regeneron Pharmaceuticals
Biotechnology
NY
2004